Developments in the use of tyrosine kinase inhibitors in the treatment of renal cell carcinoma
Author:
Affiliation:
1. Department of Medicine, Division of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2019.1573678
Reference76 articles.
1. “Cancer stat facts: kidney and renal pelvis cancer.” SEER, Available from: seer.cancer.gov/statfacts/html/kidrp.html.
2. American Cancer Society, Kidney Cancer (adult)– renal cell carcinoma. Available from: (http://www.cancer.org/cancer/kidneycancer/detailedguide/).
3. Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene
4. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma
5. Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma;Vaccines;2022-07-21
2. A Cluster of Metabolic-Related Genes Serve as Potential Prognostic Biomarkers for Renal Cell Carcinoma;Frontiers in Genetics;2022-07-07
3. Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy;Nuclear Medicine Communications;2022-04-01
4. Genitourinary cancer: A perspective review;Santosh University Journal of Health Sciences;2022
5. 18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results;European Journal of Nuclear Medicine and Molecular Imaging;2020-12-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3